Antimicrobial drug administration errors identified in Brazilian multicentric study;Erros de administração de antimicrobianos identificados em estudo multicêntrico brasileiro

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 2, 2008, Pages 305-314

  Marques, Tatiane Cristina ^a   Reis, Adriano Max Moreira ^a,b   Silva, Ana Elisa Bauer De Camargo ^a,c   Gimenes, Fernanda Raphael Escobar ^a,d   Opitz, Simone Perufo ^e   Teixeira, Thalyta Cardoso Alux ^a   Lima, Rhanna Emanuela Fontenele ^a   Cassiani, Silvia Helena De Bortoli ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d UNIVERSIDADE CAMILO CASTELO BRANCO   (Brazil)

^e UNIVERSIDADE FEDERAL DO ACRE   (Brazil)

Author keywords

Antimicrobial drugs administration errors; Medication systems hospital; Medication administration errors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BRAZIL; DRUG DOSAGE FORM; ENTEROBACTERIACEAE; ENTEROCOCCUS; HUMAN; MEDICATION ADMINISTRATION ERROR; MEDICATION ERROR; MULTICENTER STUDY; PATIENT SAFETY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; TEACHING HOSPITAL;

EID: 53849098027     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000200016     Document Type: Article

References (40)

1. ACKROYD-STOLARZ, S.; HARTNELL, N.; MACKINNON, N.J. Approaches to improving the safety of the medication use system. Healthcare Q., v.8, p.59-64, 2005.
2. AMERICAN ASSOCIATION OF HOSPITAL PHARMACISTS. ASHP. Guideline on preventing medication errors in hospitals. Am. J. Hosp. Pharm., v.50, p.305-314, 1993.
3. BARTON, T.D.; FISHMAN, N.O.; WEINER, M.G.; LAROSA, L.A.; LAUTENBACH, E. High rate of coadministration of di-or-tri-valent cation - containing compounds with oral fluoroquinolones: risk factors and potential implications. Infect. Control and Hosp. Epidemiol., v.26, p.93-99, 2005.
4. BATES, D.W. Preventing medication errors: a summary. Am. J. Health Syst. Pharm., v.64, p.S3-S9, 2007.
5. BATES, D.W.; CULLEN, D.J.; LAIRD, N.; PETERSEN, L.A.; SMALL, S.D.; SERVI, D. LAFFEL, G.; SWEITZER, B.J.; SHEA, B.F.; HALLISEY, R.; VLIET, V.M.; NEMESKAL, R.; LEAPE, L. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA, v.274, p.29-34, 1995.
6. BENJAMIN, D.M. Reducing medication errors and increasing patient safety: case studies in clinical pharmacology. J. Clin. Pharm., v.43, p.768-783, 2003.
7. BISSETT, L. Reducing the risk of acquiring antimicrobial-resistant bacteria. Br. J. Nurs., v.15, n.2, p.68-71, 2006.
8. BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Resolução n.196, de 10 de outubro de 1996. Aprova as Diretrizes e Normas Regulamentadoras de Pesquisas com seres humanos. Disponível em: 〈http://conselho.saude.gov.br/docs/Resolucoes/ Reso196.doc〉. Acesso em: 30 mar. 2005.
9. BUCKNALL, T.K. Implementing guidelines to improve medication safety for hospitalized patients: experiences from western health, Australia. Worldviews Evid. Based Nurs., v.4, n.1, p.51-53, 2007.
10. CARVALHO, V.T.; CASSIANI, S.H.B. Erros na medicação: análise das situações relatadas pelos profissionais de enfermagem. Medicina, v.33, p.322-330, 2000.
11. CASTRO, M.S. Princípios farmacocinéticos e farmacodinâmicos em antibioticoterapia. In: OLIVEIRA, A.C. Infecções hospitalares epidemiologia prevenção e controle. Rio de Janeiro: Medsi, 2005. p.357-367.
12. DANG, D.; ROBERT FEROLI, E.; GILL, C.; PAINE, L.; SHERMOCK, K.; SUFLITA, J.; WALRATH, J.M. Quest for the ideal: a redesign of the medication use system. J. Nurs. Care Qual., v.22, n.1, p.11-17, 2007.
13. DONALDSON, L.J.; FLETCHER, M.J. The WHO world alliance for patient safety: towards the of living less dangerously. Med. J. Aust., v.10, p.S69-S72, 2006.
14. ERNST, F.R.; GRIZZLE, A.J. Drug-related morbity and mortality: updating the cost-of-ilness model. J. Am. Pharm. Assoc., v.43, n.2, p.192-199, 2001.
15. FRY, M.M.; DACEY, M. Factors contributing to incidents in medicine administration. Part 1 Br. J. Nurs., v.16, n.9, p.556-559, 2007.
16. GUNTEN, V.V.; AMOS, V.; SIDLER, A.L.; BENEY, J.; TROILLET, N.; REYMOND, J.P. Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study. Pharm. World Sci., v.25, n.2, p.52-55, 2003.
17. HATCHER, I.; SULLIVAN, M.; HUTCHINSON, J.; THURMAN, S.; GAFFNEY, F.A. An intravenous medication safety system preventing high-risk medication errors at the point of care. J. Nurs. Adm., v.34, n.10, p.437-439, 2004.
18. HODGKINSON, B.; KOCH , G.S.; NAY, R.; NICHOLS, K. Strategies to reduce medications errors with reference to older adults. Int. J. Evid. Based Healthc., v.4, p.2-41, 2006.
19. HOEFEL, H.H.K.; LAUTERT, L. Errors commited by nursing technicians and assistants in administering antibiotics. Am. J. Infect. Control., v.34, p.437-442, 2006b.
20. HOEFEL, H.H.K.; LAUTERT, L. Administração endovenosa de antibióticos e resistência bacteriana: responsabilidade da enfermagem. Rev. Eletrônica Enferm., v.8, n.3, p.441-449, 2006a. Disponível em: 〈http://www.fen.ufg.br/revista/revista8_3/v8n3a15. htm.〉 Acesso em: 25 jul. 2007.
21. KLASCO, R.K. (ED): DRUGDEX® System. Thomson MICROMEDEX, Greenwood Village, Colorado, USA. 2007. Disponível em: 〈http://www.periodicos. capes.gov.br〉 Acesso em: 25 jul. 2007.
22. KOOP, B.J.; ERSTAD, B.L.; ALLEN, M.E.; THEODOROU, A.A.; PRIESTLEY, G. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit. Care Med., v.34, n.2, p.415-425, 2006.
23. KUCUKARSLAN, S.N.; PETER, M.; MLYNARECK, M.; NAFZIGER, D.A. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch. Intern. Med., v.163, p.2014-2018, 2003.
24. LAGROU, K.; VERHAEGEN, J.; PEETERMANS, W.E.; DE RIJDT, T.; MAERTENS, J.; VAN WIJNGAERDEN, E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur. J. Clin. Microbiol. Infect. Dis., v.26, p.541-547, 2007.
25. LEVY, S.B.; MARSHALL, B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med., v.10, n.12, p.S122-129, 2004.
26. MANASSE JUNIOR, H.R.; THOMPSON, K.K. Medication safety as problem in public policy. In: _. Medication safety: a guide for health care facilities. Bethesda: ASHP, 2005. p.1-15.
27. MANENTI, S.; CHAVES, A.B.; LEOPOLDINO, R.S.; PADILHA, K.G. Ocorrências adversas com medicação em unidades de terapia intensiva: análise da administração de soluções hidroeletrolíticas e antibióticos. Rev. Esc. Enferm. USP, v.32, n.4, p.369-376, 1998.
28. MANIAS, E.; AITKEN, R.; DUNNING, T. How graduate nurses use protocols to manage patients' medications. J. Clin. Nurs., v.14, p.935-944, 2005.
29. MERLE, L.; LAROCHE, M.L.; DANTONE, T.; CHAMES, J.P. Prediciting and preventing adverse drug reactions in very old. Drug Aging, v.22, n.5, p.375-392, 2005.
30. MIASSO, A.I.; GROU, C.R.; CASSIANI, S.H.B.; SILVA, A.E.B.C.; FAKIH, F.T. Erros de medicação: tipos, fatores causais e providências tomadas em quatro hospitais brasileiros. Rev. Esc. Enferm. USP, v.40, n.4, p.524-532, 2006.
31. MOUTON, J.W.; DUDLEY, M.N.; CARS, O.; DERENDORF, H.; DRUSANO, G.L. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. Int. J. Antimicrob. Agents, v.19, n.4, p.355-358, 2002.
32. MURTHY, R. Implementatation of strategies to control antimicrobial resistance. Chest, v.119, p.405S-411S, 2001.
33. MUTO, C.A.; JERNIGAN, J.A.; OSTROWSKY, B.R.; RICHET, H.E.; JARVIS, W.R.; BOYCE, J.M.; FARR, B.M. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Sthaphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol., v.24, p.362-386, 2003.
34. QUAIN, R.D.; BARTON, T.D.; FISHMAN, N.O.; WEINER, M.G.; LAUTENBACH, E. Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance. Int. J. Antimicrob. Agents, v.26, n.4, p.327-330, 2005.
35. RISSATO, M.A.R. Eventos adversos relacionados a medicamentos no contexto hospitalar: revisão da literatura. São Paulo, 2005. p.0142. [Dissertação de Mestrado. Faculdade de Saúde Pública. Universidade de São Paulo].
36. SANTELL, J.P.; COUSINS, D.D. Medication errors related to product names. Jt. Comm. J. Qual. Patient Saf., v.31, n.11, p.649-654, 2005.
37. SCHNEIDER, P.J. Opportunities for pharmacy. Am. J. Health Syst. Pharm., v.64, p.S10-S16, 2007.
38. TANG, F.I.; SHEU, S.S.; WEI, I.L.; CHEN, C. Nurse related the contributing factors involved in medication errors. J. Clin. Nurs., v.16, p.447-457, 2007.
39. WOLF, Z.R.; HICKS, R.; SEREMBUS, J.F. Characteristics of medication errors made by students during the administration phase: a descriptive study. J. Prof. Nurs., v.22, n.1, p.39-51, 2006.
40. WORLD HEALTH ORGANIZATION COLLABORATING CENTRE FOR DRUG STATISTICS METHODOLOGY. Anatomical Therapeutic Chemical (ATC) index with Defined Daily Doses (DDDs). Disponível em: 〈http://www.whocc.no/atcddd〉. Acesso em: 10 mar. 2007.